UN puts AI Titans on the hook for billions of dollars of biopiracy payments
By Jim Thomas,
Scan the Horizon
| 11. 19. 2024
It’s the wee hours of 2nd November 2024 in Cali, Colombia. In a large UN negotiating hall Colombian Environment Minister Susana Muhamed has slammed down the gavel on a decision that should send a jolt through the AI policy world. The decision, while seemingly about paying for genetic data, sets a significant wider precedent for how AI firms can be held accountable for stealing training data without consent or recompense.
Here is the context: After years of stand-offs and diplomatic wrangling, the United Nation’s Convention on Biological Diversity (UN CBD) this month adopted a landmark decision on something called “DSI”. DSI stands for Digital Sequence Information. It refers to digital versions of biological ‘codes’ such as DNA, RNA or the amino acids in proteins. These biological “codes” are routinely collected, stored and processed in digital form and have become the raw commodity powering the global$1.5 trillion dollar biotech industry. Originally sequenced from plants, animals, bacteria and viruses extracted from territories (plus human medical samples) the sheer volume of ‘DSI’ now stacking up in servers and databases rivals much of...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...